52457-99-5

Basic information

• Product Name: N-(2-propanoylphenyl)acetamide
• Synonyms: N-(2-propanoylphenyl)acetamide;2'-PROPIONYLACETANILIDE
• CAS NO: 52457-99-5
• Molecular Formula: C₁₁H₁₃NO₂
• Molecular Weight: 191.23
• Mol File: 52457-99-5.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 376.5°Cat760mmHg
• Flash Point: 162.3°C
• Appearance: /
• Density: 1.121g/cm³
• Vapor Pressure: 7.2E-06mmHg at 25°C
• Refractive Index: 1.56
• CAS DataBase Reference: N-(2-propanoylphenyl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2-propanoylphenyl)acetamide(52457-99-5)
• EPA Substance Registry System: N-(2-propanoylphenyl)acetamide(52457-99-5)

Safety Data

• Hazardous Substances Data: 52457-99-5(Hazardous Substances Data)

Usage

General Description

N-(2-propanoylphenyl)acetamide, also known as propionylphenylacetamide, is an organic compound with the chemical formula C11H13NO2. It is a white crystalline powder and is commonly used as an analgesic and antipyretic medication. This chemical is a derivative of acetanilide and is often used as a pain reliever and fever reducer. It works by inhibiting the production of prostaglandins, which are responsible for pain and inflammation. N-(2-propanoylphenyl)acetamide is also known for its mild sedative effects and is commonly found in over-the-counter medications to treat mild to moderate pain. However, it is important to use this chemical under the guidance of a healthcare professional to avoid any potential side effects.

InChI:InChI=1/C11H13NO2/c1-3-11(14)9-6-4-5-7-10(9)12-8(2)13/h4-7H,3H2,1-2H3,(H,12,13)

Upstream product

• 1196-28-7 2'-Aminopropiophenon 
• 108-24-7 acetic anhydride 
• 17408-15-0 1-(2-nitrophenyl)propanone 
• 76466-74-5 3-[3-(O-acetamido)-phenyl]-propyl alcohol 
• 75-36-5 acetyl chloride 
• 600-18-0 2-Oxobutyric acid 
• 103-84-4 Acetanilid 
• 1885-29-6 anthranilic acid nitrile 
• 123-38-6 propionaldehyde 

Downstream Products

• 188256-42-0 N-(4-bromo-2-propanoylphenyl)acetamide 
• 200617-77-2 acetic acid-(2-nitro-6-propionyl-anilide) 
• 188256-43-1 acetic acid-(4-nitro-2-propionyl-anilide) 
• 63136-60-7 4-chloro-3-methylquinoline 
• 10352-60-0 2,3-dimethylquinolin-4-ol 
• 124623-15-0 1-(2-amino-5-bromophenyl)propan-1-one 
• 124623-32-1 1-(2-amino-5-nitro-phenyl)-propan-1-one 
• 874488-29-6 1-(2-amino-3-nitro-phenyl)-propan-1-one 
• 857534-36-2 benzoic acid-(4-amino-2-propionyl-anilide) 
• 857535-80-9 benzoic acid-(4-nitro-2-propionyl-anilide) 
• 1196-28-7 2'-Aminopropiophenon 
• 1642628-04-3 (E)-N-(4-ethylquinolin-2(1H)-ylidene)-4-methylbenzenesulfonamide 
• 1642593-25-6 N-(2-(3-hydroxypent-1-yn-3-yl)phenyl)acetamide 

Relevant articles and documents

INHIBITORS OF ENL/AF9 YEATS

Methods and compositions for treating leukemia are disclosed. Acylated 6-aminoindoles, acylated 6-aminopyrrolopyridines and acylated 3-aminopyrrolo[3,2-c]pyridazines of the following formula inhibit ENL/AF9 YEATS and are therefore useful for treating leukemia.

FUSED BICYCLIC HETEROAROMATIC DERIVATIVES AS MODULATORS OF TNF ACTIVITY

A series of substituted heteroaromatic compounds containing two fused six- membered rings,tivity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and ne

2-Arylaminopyrimidine derivatives as PLK inhibitors

Anilino-pyrimidine and 1,2,4-triazine compounds (1) are new. Anilino-pyrimidine and 1,2,4-triazine compounds of formula (1), their tautomers, racemates, enantiomers and/or diastereomers and acid-addition salts are new. X : NR 1a>, O or S; Y : CH or N; Z : hydrogen, halo, (halo)1-3C alkyl, 2-3C alkenyl, 2-3C alkynyl, formyl, 1-3C (halo)alkylcarbonyl, 2-3C alkenyl-, 2-3C alkynyl-carbonyl or pseudohalo; A : (hetero)aryl group (i) or (ii); R a> - R f>e.g. hydrogen, halo or nitro; R 1> and R 1a>hydrogen or methyl; R 2>e.g. Cl, Br, I, OR 6>; R 3>e.g. -CONR 1>-L-Q 3-Q 4-R 9>, -NR 1>-CO-L-Q 3-Q 4-R 9>; R 4>e.g. OR 6>, COR 6>, CONR 6>R 7>, NR 6>R 7>, NR 6>COR 7>, NR 6>SO 2R 7>, N=CR 6>R 7>, SR 6>, SOR 6>, SO 2R 6>, SO 2NR 6>R 7> or pseudohalogen, or any of 1-8C alkyl, 2-10C alkenyl or alkynyl, 3-8C cycloalkyl, (hetero)aryl or heterocyclyl; R 5>hydrogen, halo, trifluoromethyl, 1-3C alkyl or OR 6>; R 6>, R 7>e.g. hydrogen or any of 1-5C alkyl, 2-5C alkenyl or alkynyl, 3-10C cycloalkyl, (hetero)aryl or heterocyclyl; L : e.g. bond or residue of 1-16C alkyl, 2-16C alkenyl or alkynyl, 3-10C cycloalkyl, (hetero)aryl or heterocyclyl; Q 3 and Q 4bond or a mono- or bi-cyclic heterocyclyl, optionally substituted by one or more of Me, Et, halo, amino, hydroxy or pseudohalo; R 9>as L but not a bond; and T : N, O or S. Full definitions are given in the DEFINITIONS (Full Definitions) field. [Image] [Image] ACTIVITY : Cytostatic; Antiinflammatory; Immunosuppressive; Virucide; Anti-HIV; Dermatological; Nootropic; Neuroprotective; Nephrotropic; Vulnerary; Antibacterial; Fungicide; Antiparasitic; Antipsoriatic; Osteopathic; Cardiovascular-Gen; Vasotropic; Gastrointestinal-Gen. MECHANISM OF ACTION : Kinase inhibitor; Polo-like kinase (PLK) inhibitor. In a trial, (1) was found to have EC 50 against recombinant human PLK1 of below 5, generally 1 mu M. No results for specific compounds were given.